PNC Financial Services Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

PNC Financial Services Group’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,020	Closed	-$76K	–	4085
2020 Q1	$76K	Buy	1,020 +46	+5%	+$5.3K	﹤0.01%	2391
2019 Q4	$134K	Sell	974 -48	-5%	-$5.84K	﹤0.01%	2318
2019 Q3	$122K	Buy	1,022 +34	+3%	+$4.75K	﹤0.01%	2431
2019 Q2	$138K	Buy	988 +334	+51%	+$58.7K	﹤0.01%	2388
2019 Q1	$116K	Buy	+654	New	+$98.3K	﹤0.01%	2471

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PNC Financial Services Group's ORTX Position: Q2 2020 in Review

PNC Financial Services Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2020, closing a stake of 1,020 shares — an estimated $76K sold.

PNC Financial Services Group first reported a position in ORTX in Q1 2019 and held it in 5 quarters. The position peaked at $138K in Q2 2019. 81 funds tracked by Wall St. Rank hold ORTX as of Q2 2020.

PNC Financial Services Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
PNC Financial Services Group sold 1,020 Orchard Therapeutics plc American Depositary Shares shares in Q2 2020, an estimated $76K.
PNC Financial Services Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2019 and held it in 5 quarters.
PNC Financial Services Group's Orchard Therapeutics plc American Depositary Shares position peaked at $138K in Q2 2019.
81 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2020.

Based on PNC Financial Services Group's 13F filing for Q2 2020, filed 7 Aug 2020.